logo
logo

Shanghai Zhenge Biotech Raises Usd 100 Million Round C Led By Goldman Sachs Asset Management And Sofina

Shanghai Zhenge Biotech Raises Usd 100 Million Round C Led By Goldman Sachs Asset Management And Sofina

01/11/22, 9:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CN.svgshanghai
Money raised
$100 million
Shanghai ZhenGe Biotech Co., Ltd. ("ZhenGe Biotech" or "the Company") announced the completion of round C financing of US $100 million, led by Goldman Sachs Asset Management and Sofina. Also investing were Novo Holdings A/S, Qiming Venture Capital, IDG Capital, LYFE Capital, Junxin Capital and Cowin Capital.

Company Info

Company
Zhen Ge Biotech
Location
shanghai, shanghai, china
Additional Info
Shanghai ZhenGe Biotech was founded in 2017. ZhenGe Biotech's core business is macromolecular biological drug CDMO service, mammalian cell culture medium development and production, etc. Specifically, its services include: macromolecule developability analysis, cell line development, process development and optimization, pilot production, clinical sample production and commercial CMO services, process characterization and validation research, drug analysis services, cell culture medium formulation development and commercial production, etc. SOURCE Shanghai ZhenGe Biotech